Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Early clinical trials have shown large, dose-related weight loss in people with obesity
Residual gastric contents can increase the risk of regurgitation, aspiration pneumonia, respiratory distress, lung inflammation, or other serious perioperative complications during surgery or endoscopic procedures
DFO ameliorates these changes by reducing mitochondrial ROS, protecting DA neurons, and inhibiting ferroptosis (273)
designed PtCu 3 -PEG nanocages, which can serve as horseradish peroxidase-like and GSH peroxidase-like nanozymes for enhanced ROS-based therapy by exhaustion of GSH (Zhong et al., 2020)
US$ 24.00
US$ 21.42
US$ 28.08
US$ 29.19
US$ 22.77
US$ 22.17
US$ 24.53
US$ 29.91
